PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Mental Health Technologies Co.,Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Mental Health Technologies Co.,Ltd. owes ¥0.72 for every ¥1 it owns. Mental Health Technologies Co.,Ltd. returned to profit in the year to Dec 2025, after a loss the year before.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

34.6

Investors pay ¥34.6 for every ¥1 of Mental Health Technologies Co.,Ltd.'s yearly profit, higher than 87% of Healthcare companies in Japan.

P/B ratio

5.02

The share price is 5.02 times Mental Health Technologies Co.,Ltd.'s book value per share, higher than 88% of Healthcare companies in Japan.

Market cap

¥8.1 B

The total market value of all of Mental Health Technologies Co.,Ltd.'s shares at today's price (share price × number of shares), smaller than 65% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥1.6 B

What Mental Health Technologies Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥153.24

Net worth divided by the number of shares. The share price of ¥769.00 is 5.0 times this, which is the P/B above.

Return on equity (ROE)

15.4%

Mental Health Technologies Co.,Ltd. earned 15.4% on its shareholders' money over the last year, higher than 83% of Healthcare companies in Japan.

Owes vs Owns

0.72×

Mental Health Technologies Co.,Ltd. owes ¥0.72 for every ¥1 it owns (moderate), higher than 87% of Healthcare companies in Japan.

Dividend yield

1.27%

Mental Health Technologies Co.,Ltd. pays 1.27% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in Japan.

Revenue growth

+25%

Revenue rose 25% in the year to Dec 2025, and grew 41% a year on average over 3 years.

Profit growth

Back to profit

Mental Health Technologies Co.,Ltd. returned to profit in the year to Dec 2025, after a loss the year before.

Profit margin

4.0%

Mental Health Technologies Co.,Ltd. keeps ¥4 of every ¥100 of revenue as net profit.

Cash quality

2.5×

Cash from Mental Health Technologies Co.,Ltd.'s business was 2.5× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

14.3×

Mental Health Technologies Co.,Ltd.'s operating profit covered its interest costs 14.3 times in the year to Dec 2025.

Cash vs debt

Net debt

Mental Health Technologies Co.,Ltd. had ¥1.1 B more debt than cash (net debt) at Dec 2025.

Questions

What is Mental Health Technologies Co.,Ltd.'s P/E ratio?

Investors pay ¥34.6 for every ¥1 of Mental Health Technologies Co.,Ltd.'s yearly profit, higher than 87% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Mental Health Technologies Co.,Ltd.: ¥8.1 B ÷ ¥1.6 B (30 Jun 2026) = 5.0.

What is Mental Health Technologies Co.,Ltd.'s return on equity?

Mental Health Technologies Co.,Ltd. earned 15.4% on its shareholders' money over the last year, higher than 83% of Healthcare companies in Japan.

How much does Mental Health Technologies Co.,Ltd. owe compared with what it owns?

Mental Health Technologies Co.,Ltd. owes ¥0.72 for every ¥1 it owns (moderate), higher than 87% of Healthcare companies in Japan.

Does Mental Health Technologies Co.,Ltd. pay a dividend?

Yes. Mental Health Technologies Co.,Ltd. pays 1.27% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in Japan.

Is Mental Health Technologies Co.,Ltd.'s revenue growing?

Revenue rose 25% in the year to Dec 2025, and grew 41% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.